0

Using Real-World Data for Patients with Multiple Sclerosis: A New Machine Learning Model for the Expanded Disability Status Scale (EDSS)

  Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds and protects the nerve fibers of the central nervous system. The result is a disabling disease that causes damage to… Continue Reading

0

Delivering Real World Data-Driven Insights: An Executive Interview with Wendy Shusko and Jason Drenning

Delivering Real World Data-Driven Insights:An Executive Interview with Wendy Shusko and Jason Drenning Wendy Shusko, President and CEO and Jason Drenning, PhD, Chief Commercial Officer of STATinMED Research sat down with HealthEconomics.Com to discuss the data landscape, industry trends and… Continue Reading

0

Real-world evidence and value-based contracting – swipe left or swipe right?

As biopharma makes the shift toward a personalized healthcare system, it is also transitioning towards a pipeline full of innovative, high-cost therapies. We are moving to a value-based system, with two of the biggest ideas for this decade becoming more… Continue Reading

0

Key Elements of a Real-World Evidence Generation Plan: Integration of Product Support Activities

Shelby CormanPharmerit International Real-world evidence is a key component of value demonstration for pharmaceuticals, diagnostic agents, and medical devices throughout the product lifecycle. Planning for real-world evidence needs early in the pre-launch period can allow for seamless integration of health… Continue Reading

0

Benchmarking Survey: Can we reduce procurement time in HEOR & RWE?

As healthcare moves towards an increased focus on outcomes and value, health economics & outcomes research (HEOR) and real-world evidence (RWE) are being used to guide value-based decisions, improve outcomes, reduce costs, and achieve market access. This move toward new… Continue Reading